Certificate of Analysis
Third Party Tested • ISO/IEC 17025 Accredited • Premium Quality
Purity: 99.20% (✓ Passed Full QC Panel)
Specification Specification
| Variant | |
| KPV | 10mg |
| Lot # | |
| KPV | 0001 |
| Labeled | 10mg |
| Actual | 10.58mg |
| Tested | May 29, 2026 |
| Full QC Panel | 7× tested |
| Purity (HPLC) | 99.20% |
| Net Peptide Content | 10.58mg |
| Identity (HPLC) | |
| KPV | |
| HPLC Conformity | mean 99.18% |
| Heavy Metals (ICP-MS) | Not Detected |
| Sterility (PCR) | No Growth |
| Endotoxin (USP <85>) | < 0.05 EU/mLISO/IEC 17025 AccreditedSelected dosage99.49%Purity |
Specification Specification
| Variant | |
| KPV | 10mg |
| Lot # | KP1120 |
| Labeled | 10mg |
| Actual | 13.76mg |
| Tested | Feb 4, 2026 |
Frequently Researched Together
Tripeptide research compounds
Molecular Profile
What Is KPV?
| Type | Synthetic tripeptide |
| Sequence | Lys-Pro-Val ( |
| KPV | )Amino acids3Molecular formulaC₁₆H₃₀N₄O₄Molecular weight342.43 g/mol |
| CAS Number | 67727-97-3Originα-MSH residues 11-13 |
| PubChem Database | |
Parent Compound
Relationship to α-MSH
Parent peptideα-Melanocyte-Stimulating Hormoneα-MSH length13 amino acids
| KPV | positionC-terminal (11-13)Activity retainedAnti-inflammatory effectsMCR bindingNOT required for activityBr J Pharmacol Review |

